FDA Overreaches in Jurisdictional Power Grab
This article was originally published in RPM Report
Executive Summary
Letter to Dysport clinical investigator claims promotional violations in magazine interviews. Do clinical investigators really sign away their right to free speech when they conduct a clinical trial for a drug company?